Status
Conditions
About
Evaluation of long-term efficacy outcomes of patients previously treated with the Alpha DaRT seeds for management of their malignancy following initial response.
Full description
Medical records of patients that previously underwent the Alpha DaRT treatment will be reviewed by an authorized staff member.
Evaluation of long-term outcomes of patients previously treated with the Alpha DaRT seeds for management of their malignancy following initial response. These outcomes include:
Safety - assessment of late onset of Alpha DaRT related AE in patients treated with the Alpha DaRT seeds
Efficacy -
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
None.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal